Lymphovascular space invasion and Estrogen Receptor status in high-grade serous ovarian cancer-a multicenter study by the FRANCOGYN group.

Date publication

octobre 2021

Journal

Journal of gynecology obstetrics and human reproduction

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles , Pr AKLADIOS Chérif

Tous les auteurs :
Lorenzini J, Deberti M, Body G, Carcopino X, Touboul C, Dabi Y, Collinet P, Coutant C, Akladios C, Lavoué V, Bolze PA, Huchon C, Bricou A, Canlorbe G, Mimoun C, Bendifallah S, Ouldamer L,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34715402

Résumé

The aim of this study was to evaluate the impact of Lymphovascular Space Invasion (LVSI) on Overall Survival (OS) and Recurrence-Free Survival (RFS) in patients managed for high-grade serous epithelial ovarian cancer (HGSOC).

Mots clés

High-Grade Serous, Lymphovascular Space Invasion, Overall Survival, Prognosis, Recurrence-Free Survival

Référence

J Gynecol Obstet Hum Reprod. 2021 Oct 26;:102242